SOAT1 and Hepatic fibrosis: This study showed a significant decline of alkaline phosphatase serum levels, a marker for the activity and prognosis of PSC in treated patients.94 In conclusion, although the definite role of the JAK-STAT pathway in liver fibrosis is not established, and probably depends on disease state and cell type, most in vivo results on JAK inhibition are promising.